Buy Stocks Easy | About Us
January 26, 2021
Buy Stocks Easy | Online Stocks

GEMP


Buy Gemphire Therapeutics Inc. Stock (symbol: GEMP) Easy Online

Company Name: Gemphire Therapeutics Inc.

Symbol: GEMP

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2016

GEMP Current Share Price

Today's GEMP ( Gemphire Therapeutics Inc. ) opening price: $0.2999

Yesterday's GEMP ( Gemphire Therapeutics Inc. ) closing price: $0.2894

Gemphire Therapeutics Inc. Stock ( symbol: GEMP ) Price Chart since IPO (2016):

12 Months Gemphire Therapeutics Inc. Stock ( symbol: GEMP ) Price Chart

Popular Questions about Gemphire Therapeutics Inc. Public Stock ( GEMP )

A: Gemphire Therapeutics Inc. stock symbol (also called stock or share ticker) is GEMP

A: Gemphire Therapeutics Inc. IPO (Initial Public Offering) took place on 2016

A: Gemphire Therapeutics Inc.'s stock (GEMP symbol) price at ther IPO (initial Public Offering) was $0.2999

Q: Is GEMP stock worth buying at the moment?

A: The GEMP stock performance since 2019 are rather disappointing. If you had bought 1 share of Gemphire Therapeutics Inc. stock (symbol: GEMP) at the beginning of 2019, at the opening share price of $1.0700, you would be left with exactly $0.2999 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Gemphire Therapeutics Inc. Stock Easy Online

Gemphire Therapeutics Inc. Stock Ticker Price Chart since IPO:





Gemphire Therapeutics Inc. Stock Price Yesterday



 


Gemphire Therapeutics Inc. Stock Price – Last Week




 


Gemphire Therapeutics Inc. Stock Price – Last Month




 


Gemphire Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/30/1965077/0/en/Gemphire-Therapeutics-Announces-Expected-Closing-Date-of-Merger-with-NeuroBo-Pharmaceuticals.html
                            

                                
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals

                                
                                
ANN ARBOR, Mich., Dec.  30, 2019  (GLOBE NEWSWIRE) -- The pending m...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/06/1957305/0/en/Gemphire-Therapeutics-Announces-Stockholder-Approval-of-Proposals-Required-for-Merger-with-NeuroBo-Pharmaceuticals.html
                            

                                
Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo Pharmaceuticals

                                
                                
ANN ARBOR, Mich., Dec.  06, 2019  (GLOBE NEWSWIRE) -- Gemphire Ther...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/07/14133880/gemphire-flirts-with-1-level-as-struggling-biotech-strikes-reverse-merger-deal
                            

                                
Gemphire Flirts With $1 Level As Struggling Biotech Strikes Reverse Merger Deal

                                
                                
Gemphire Therapeutics Inc (NASDAQ: GEMP) stock — which has been on ...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/news/19/06/13987286/gemphire-therapeutics-falls-20-after-oral-cholesterol-drug-trial-results
                            

                                
Gemphire Therapeutics Falls 20% After Oral Cholesterol Drug Trial Results

                                
                                
Gemphire Therapeutics (NASDAQ: GEMP) shares are trading lower after...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4266688-gemphire-gemcabene-orphan-first-approach-excellent-clinical-refocus?source=feed_tag_long_ideas
                            

                                
Gemphire And Gemcabene: The Orphan First Approach Is An Excellent Clinical Refocus

                                
                                
My last two articles on Gemphire Therapeutics focused on the scient...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/30/1965077/0/en/Gemphire-Therapeutics-Announces-Expected-Closing-Date-of-Merger-with-NeuroBo-Pharmaceuticals.html
                            

                                
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals

                                
                                
ANN ARBOR, Mich., Dec.  30, 2019  (GLOBE NEWSWIRE) -- The pending m...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/06/1957305/0/en/Gemphire-Therapeutics-Announces-Stockholder-Approval-of-Proposals-Required-for-Merger-with-NeuroBo-Pharmaceuticals.html
                            

                                
Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo Pharmaceuticals

                                
                                
ANN ARBOR, Mich., Dec.  06, 2019  (GLOBE NEWSWIRE) -- Gemphire Ther...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/07/14133880/gemphire-flirts-with-1-level-as-struggling-biotech-strikes-reverse-merger-deal
                            

                                
Gemphire Flirts With $1 Level As Struggling Biotech Strikes Reverse Merger Deal

                                
                                
Gemphire Therapeutics Inc (NASDAQ: GEMP) stock — which has been on ...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/news/19/06/13987286/gemphire-therapeutics-falls-20-after-oral-cholesterol-drug-trial-results
                            

                                
Gemphire Therapeutics Falls 20% After Oral Cholesterol Drug Trial Results

                                
                                
Gemphire Therapeutics (NASDAQ: GEMP) shares are trading lower after...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4266688-gemphire-gemcabene-orphan-first-approach-excellent-clinical-refocus?source=feed_tag_long_ideas
                            

                                
Gemphire And Gemcabene: The Orphan First Approach Is An Excellent Clinical Refocus

                                
                                
My last two articles on Gemphire Therapeutics focused on the scient...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.